NCT04491669

Brief Summary

The aim of the current study is to screen different causes and characteristics of Gastrointestinal bleeding in Chronic Renal Failure patients at Assuit University Hospital according to their stages based on e GFR (Stage I to IV), in order to assess different modalities of therapeutic intervention from medical therapy up to therapeutic intervention.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 29, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

July 29, 2020

Status Verified

July 1, 2020

Enrollment Period

1 year

First QC Date

July 25, 2020

Last Update Submit

July 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessment of different modalities of therapeutic intervention.

    medical therapy up to therapeutic intervention data will be received.

    one year from October 2020 to October 2021

Interventions

Chronic Renal Failure staging according to GFR by Chronic Renal Failure EPI is: * Stage1 in which GFR\>90 mil/min but evidence of kidney damage. * Stage 2 GFR 60-89 mil/min. * Stage 3 GFR 30-95 mil/min. * Stage 4 GFR 15-29 mil/min. * Stage 5 GFR\<15 mil/min.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Chronic Renal Failure patients with different stages (stage I to IV) according to the National Kidney Foundation are recruited from inpatients of renal unit in internal medicine department, Assuit university hospitals.

You may qualify if:

  • One hundred Chronic Renal Failure patients with different stages (stage I to IV) according to the National Kidney Foundation are recruited from inpatients of renal unit in internal medicine department, Assuit university hospitals. Their GFR will assessed by using Chronic Renal Failure EPI equation measured as GFR=166 x(s cr/0.7)-1.209X(0.993)age if female, and GFR=163X(s cr/0.9)-1.209x(0.993)age if male. (Andrews et al 2008).
  • Chronic Renal Failure staging according to GFR by Chronic Renal Failure EPI is:
  • Stage1 in which GFR\>90 mil/min but evidence of kidney damage.
  • Stage 2 GFR 60-89 mil/min.
  • Stage 3 GFR 30-95 mil/min.
  • Stage 4 GFR 15-29 mil/min.
  • Stage 5 GFR\<15 mil/min.

You may not qualify if:

  • All Patients with local causes of Gastrointestinal Bleeding
  • Benign and Malignant tumors in Gastrointestinal Tract.
  • Patients with Hemorrhoids or anal fissures.
  • Patients with Mallory-Weiss tears.
  • patients with Diverticular disease.
  • patients with Colon polyps.
  • patients with infectious causes of GIT bleeding (Salmonella, Shigella)
  • patients with Angiodysplasia.
  • patients with Esophageal varices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P; International Consensus Upper Gastrointestinal Bleeding Conference Group. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010 Jan 19;152(2):101-13. doi: 10.7326/0003-4819-152-2-201001190-00009.

    PMID: 20083829BACKGROUND
  • Zuccaro G Jr. Management of the adult patient with acute lower gastrointestinal bleeding. American College of Gastroenterology. Practice Parameters Committee. Am J Gastroenterol. 1998 Aug;93(8):1202-8. doi: 10.1111/j.1572-0241.1998.00395.x. No abstract available.

    PMID: 9707037BACKGROUND
  • Kim BS, Li BT, Engel A, Samra JS, Clarke S, Norton ID, Li AE. Diagnosis of gastrointestinal bleeding: A practical guide for clinicians. World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):467-78. doi: 10.4291/wjgp.v5.i4.467.

    PMID: 25400991BACKGROUND
  • Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.

    PMID: 23732715BACKGROUND
  • Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019 Apr;23(4):437-447. doi: 10.1007/s10157-018-1641-8. Epub 2018 Sep 3.

    PMID: 30178234BACKGROUND

MeSH Terms

Conditions

Gastrointestinal Hemorrhage

Interventions

Glomerular Filtration Rate

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Kidney Function TestsDiagnostic Techniques, UrologicalDiagnostic Techniques and ProceduresDiagnosisUrinary Tract Physiological PhenomenaReproductive and Urinary Physiological Phenomena

Study Officials

  • Effat AH Tony, Prof. Dr.

    Assiut University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

July 25, 2020

First Posted

July 29, 2020

Study Start

October 1, 2020

Primary Completion

October 1, 2021

Study Completion

December 1, 2021

Last Updated

July 29, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share